Title:
USE OF BENZOYLGUANIDINES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS
Document Type and Number:
WIPO Patent Application WO2000030624
Kind Code:
A3
Abstract:
(57) Abstract The invention relates to the use of benzoylguanidines of formula (I) wherein R<1> is A; R<2> is Het, CnFmH2n+1-mOp, R<4>, OR<4>, OH, benzyl, CN, Hal, SOq-R<5>, Ph, O-Ph, O-Het, NH-Het, NH2, NHA, NA2 or NH-Ph; R<3> is SO2A'; R<4> is a straight-chain or branched alkyl radical having 1 to 8 C atoms or cycloalkyl having 3 to 8 C atoms which can be unsubstituted or mono-, di- or trisubstituted by A; R<5> is A or Ph; A, A' in each case independently of one another are alkyl having 1 to 6 C atoms, and/or their physiologically acceptable salts and solvates for the production of a medicament for the treatment of non-insulin-dependent diabetes mellitus.
More Like This:
Inventors:
GERICKE ROLF (DE)
BAUMGARTH MANFRED (DE)
MINCK KLAUS (DE)
MESANGEAU DIDIER (FR)
DOARE LILIANE (FR)
KERGOAT MICHELINE (FR)
BAUMGARTH MANFRED (DE)
MINCK KLAUS (DE)
MESANGEAU DIDIER (FR)
DOARE LILIANE (FR)
KERGOAT MICHELINE (FR)
Application Number:
PCT/EP1999/008795
Publication Date:
October 05, 2000
Filing Date:
November 16, 1999
Export Citation:
Assignee:
MERCK PATENT GMBH (DE)
GERICKE ROLF (DE)
BAUMGARTH MANFRED (DE)
MINCK KLAUS (DE)
MESANGEAU DIDIER (FR)
DOARE LILIANE (FR)
KERGOAT MICHELINE (FR)
GERICKE ROLF (DE)
BAUMGARTH MANFRED (DE)
MINCK KLAUS (DE)
MESANGEAU DIDIER (FR)
DOARE LILIANE (FR)
KERGOAT MICHELINE (FR)
International Classes:
A61K31/155; A61K31/166; A61K31/40; C07D207/327; A61K31/402; A61P3/10; A61P5/48; C07C279/22; (IPC1-7): A61K31/155; A61K31/40; A61P5/48
Foreign References:
EP0699666A1 | 1996-03-06 | |||
EP0743301A2 | 1996-11-20 | |||
EP0699663A1 | 1996-03-06 | |||
EP0760365A2 | 1997-03-05 | |||
EP0723963A1 | 1996-07-31 | |||
EP0708088A1 | 1996-04-24 | |||
EP0725062A1 | 1996-08-07 |
Other References:
BAUMGARTH M ET AL: "(2-Methyl-5(methylsufonyl)benzoyl) guanidine Na+/H+ antiporter inhibitors", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, vol. 40, no. 13, 20 June 1997 (1997-06-20), pages 2017 - 2034-34, XP002121770, ISSN: 0022-2623
Download PDF:
Previous Patent: AGENT FOR LOWERING PROLACTIN
Next Patent: USE OF PHOSPHONOFORMIC ACID DERIVATIVES FOR TREATING INFECTIONS
Next Patent: USE OF PHOSPHONOFORMIC ACID DERIVATIVES FOR TREATING INFECTIONS